ARCHIVES

In Brief: House Passes Bill Extending Saccharin Status To 1981; Execs No Enthusiastic Over New SES

This article is from The Cancer Letter archive.

Vol. 05 No. 31 | August 3, 1979

Download PDF Visit The Full Archive

Related Articles

“Whatever Happened To…?” ACS Follows Up Five Years Later

August 26, 1977

Center Grant Review Tougher, Yarbro Insists

May 23, 1975

Trial Shows Standard-Dose Radiotherapy Safer, More Effective than Higher Doses

May 31, 2013

LabCorp Marketing Of Ovarian Cancer Test Unlawful, FDA Says In Warning Letter.

October 17, 2008

FDA carries Action On Two Cancer Drugs Over To 1996

January 5, 1996

In a letter, ASCO reaffirms its views on oncology consolidation at FDA.

July 9, 2004